Research Topic

RNA and RNA Modification in the Pathogenesis, Diagnosis and Treatment of Cancers

About this Research Topic

With the recent approval of mRNA vaccines for the prevention of COVID-19 by the U.S. Food and Drug Administration and its successful application, we envision the rapid advancement of the modification of RNA in cancer diagnosis, prevention and treatment in the near future. RNA modification includes RNA synthesis and RNA interference. With advanced sequencing techniques, public depository of raw sequencing data, and bioinformatics, a number of RNA-related subjects such as; endogenously produced microRNAs (miRNAs) and non-coding RNAs (ncRNAs), and exogenously introduced small interfering RNAs (siRNAs), short-hairpin RNAs (shRNAs), and CRISPR RNAs, their target genes, and the pathways they involve, have all been reported to form a vast interconnected network system. These subjects are seen in the pathological development, diagnosis, and prognosis of cancers and are therefore potential targets of drug development for cancer treatment.

The purpose of this research topic is to update the basic, translational, and clinical research on the biological and functional roles of RNA modification in various aspects of cancers, such as; cancer pathogenesis, cancer cell proliferation, migration, invasion, metastasis, drug resistance, diagnosis, prognosis, treatment development, as well as novel drug discovery. This topic collection will help broaden our knowledge on RNA modification in combating cancer related diseases.

This Research Topic welcomes original research, case reports, commentaries and review (including meta-analysis and systematic reviews) articles that focus on, but not limited to, the following topics:
- Technology to identify and analyze RNAs and their target genes
- Techniques to deliver siRNA and shRNA into target cells and the off-target effects
- Modification of RNAs in cancer cell proliferation, metastasis and cancer drug resistance
- RNAs in cancer immune regulation, immunotherapy and inflammatory response
- RNAs in cancer diagnosis, prognosis, treatment, and drug development
- RNAs in other aspects of cancers

Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.


Keywords: RNA, pathogenesis, diagnosis, prognosis, cancer, treatment


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

With the recent approval of mRNA vaccines for the prevention of COVID-19 by the U.S. Food and Drug Administration and its successful application, we envision the rapid advancement of the modification of RNA in cancer diagnosis, prevention and treatment in the near future. RNA modification includes RNA synthesis and RNA interference. With advanced sequencing techniques, public depository of raw sequencing data, and bioinformatics, a number of RNA-related subjects such as; endogenously produced microRNAs (miRNAs) and non-coding RNAs (ncRNAs), and exogenously introduced small interfering RNAs (siRNAs), short-hairpin RNAs (shRNAs), and CRISPR RNAs, their target genes, and the pathways they involve, have all been reported to form a vast interconnected network system. These subjects are seen in the pathological development, diagnosis, and prognosis of cancers and are therefore potential targets of drug development for cancer treatment.

The purpose of this research topic is to update the basic, translational, and clinical research on the biological and functional roles of RNA modification in various aspects of cancers, such as; cancer pathogenesis, cancer cell proliferation, migration, invasion, metastasis, drug resistance, diagnosis, prognosis, treatment development, as well as novel drug discovery. This topic collection will help broaden our knowledge on RNA modification in combating cancer related diseases.

This Research Topic welcomes original research, case reports, commentaries and review (including meta-analysis and systematic reviews) articles that focus on, but not limited to, the following topics:
- Technology to identify and analyze RNAs and their target genes
- Techniques to deliver siRNA and shRNA into target cells and the off-target effects
- Modification of RNAs in cancer cell proliferation, metastasis and cancer drug resistance
- RNAs in cancer immune regulation, immunotherapy and inflammatory response
- RNAs in cancer diagnosis, prognosis, treatment, and drug development
- RNAs in other aspects of cancers

Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.


Keywords: RNA, pathogenesis, diagnosis, prognosis, cancer, treatment


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

22 August 2021 Abstract
03 January 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

22 August 2021 Abstract
03 January 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..